The Mayo Clinic and invited guest faculty aim to educate participants about CAR-T cell therapy, therapies beyond B-Cell malignancies, challenges of CAR-T cell therapy, and how to build a CAR-T Program. The program highlights the future directions in CAR-T cell therapy and cellular therapeutics, the practical management of patients receiving CAR-T cell therapy, demonstrate the ability to work in inter-disciplinary teams in the context of CAR-T cell therapy, and target patient populations well suited for CAR-T cell therapy.
General Session: USD 275.0
Speakers: Yi Lin, M.D., Ph. D., Saad Kenderian, M.D., Elizabeth Budde, M.D., Ph. D., Caron Jacobson, M.D., Marco Ruella, M.D., Saar Gill, M.D., Ph. D., Maksim Mamonkin, Ph.D., Januario Castro, M.D., Ph. D., Dennis Gastineau, M.D., Jason Barreto, Pharm D, Mohamed Kharfan Dabaja, M.D., M.B.A., Allison McClanahan, APRN, C.N.P., Adrienne Nedved, Pharm D, Megan Spychalla, P.A.-C.